Randomized Controlled Trial starting in Germany and Switzerland

16th March 2020

A breakthrough research project in partnership with St. Clara Research Ltd, St. Claraspital will look at the gut-brain interactions and the effect of a low-carb dietary intervention in obese and depressive patients. Starting in 2020, patients will use Gro and follow a low-carb diet according to the clinically-validated Low Carb Program delivered through the Gro app.

This interventional study will be a multi-centre, binational project looking at patients from both St. Clara Research Ltd at St. Claraspital Basel in Basel, Switzerland and Universitätsklinikum Schleswig-Holstein, Germany.

The study was funded by the Swiss National Science Foundation through Sinergia, which promotes the interdisciplinary collaboration of two to four applicants who propose breakthrough research.